Vaccinia virus

"Vaccinia virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.

Descriptor ID	D014616
MeSH Number(s)	B04.280.650.160.650.900
Concept/Terms	Vaccinia virus Vaccinia virus Vaccinia viruses Poxvirus officinale Rabbitpox virus Rabbitpox virus Rabbitpox viruses Rabbit Pox Virus Rabbit Pox Viruses Buffalopox virus Buffalopox virus Buffalopox viruses virus, Buffalopox Buffalo Pox Virus Buffalo Pox Viruses Virus, Buffalo Pox Viruses, Buffalo Pox

Below are MeSH descriptors whose meaning is more general than "Vaccinia virus".

Organisms [B]
Viruses [B04]
DNA Viruses [B04.280]
Poxviridae [B04.280.650]
Chordopoxvirinae [B04.280.650.160]
Orthopoxvirus [B04.280.650.160.650]
Vaccinia virus [B04.280.650.160.650.900]

Below are MeSH descriptors whose meaning is related to "Vaccinia virus".

Below are MeSH descriptors whose meaning is more specific than "Vaccinia virus".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vaccinia virus" by people in this website by year, and whether "Vaccinia virus" was a major or minor topic of these publications.

Bar chart showing 11 publications over 10 distinct years, with a maximum of 2 publications in 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2003	0	1	1
2004	1	0	1
2006	2	0	2
2009	1	0	1
2013	1	0	1
2014	0	1	1
2015	1	0	1
2017	1	0	1
2018	1	0	1

Below are the most recent publications written about "Vaccinia virus" by people in Profiles.

Ram?rez M, Santos S, Mart?nez O, Rodr?guez R, Miranda E, Ramos-Perez WD, Otero M. Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA. Vaccine. 2018 04 05; 36(15):2049-2055.

View in: PubMed
Reed B, Yakovleva L, Shuman S, Ghose R. Characterization of DNA Binding by the Isolated N-Terminal Domain of Vaccinia Virus DNA Topoisomerase IB. Biochemistry. 2017 07 05; 56(26):3307-3317.

View in: PubMed
Mart?nez O, Bravo Cruz A, Santos S, Ram?rez M, Miranda E, Shisler J, Otero M. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge. Vaccine. 2017 10 20; 35(44):6007-6014.

View in: PubMed
Spencer CT, Bezbradica JS, Ramos MG, Arico CD, Conant SB, Gilchuk P, Gray JJ, Zheng M, Niu X, Hildebrand W, Link AJ, Joyce S. Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules. Proteomics Clin Appl. 2015 Dec; 9(11-12):1035-52.

View in: PubMed
Guan H, Nuth M, Zhukovskaya N, Saw YL, Bell E, Isaacs SN, Ricciardi RP. A novel target and approach for identifying antivirals against molluscum contagiosum virus. Antimicrob Agents Chemother. 2014 Dec; 58(12):7383-9.

View in: PubMed
Gilchuk P, Spencer CT, Conant SB, Hill T, Gray JJ, Niu X, Zheng M, Erickson JJ, Boyd KL, McAfee KJ, Oseroff C, Hadrup SR, Bennink JR, Hildebrand W, Edwards KM, Crowe JE, Williams JV, Buus S, Sette A, Schumacher TN, Link AJ, Joyce S. Discovering naturally processed antigenic determinants that confer protective T cell immunity. J Clin Invest. 2013 May; 123(5):1976-87.

View in: PubMed
Hu N, Yu R, Shikuma C, Shiramizu B, Ostrwoski MA, Yu Q. Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells. Vaccine. 2009 May 14; 27(22):2994-3006.

View in: PubMed
Yu Q, Jones B, Hu N, Chang H, Ahmad S, Liu J, Parrington M, Ostrowski M. Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage. Vaccine. 2006 Sep 29; 24(40-41):6376-91.

View in: PubMed
Ellenberger D, Otten RA, Li B, Aidoo M, Rodriguez IV, Sariol CA, Martinez M, Monsour M, Wyatt L, Hudgens MG, Kraiselburd E, Moss B, Robinson H, Folks T, Butera S. HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. Virology. 2006 Aug 15; 352(1):216-25.

View in: PubMed
Otero M, Calarota SA, Dai A, De Groot AS, Boyer JD, Weiner DB. Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy. Vaccine. 2006 May 22; 24(21):4461-70.

View in: PubMed

People

Explore

Similar Concepts

Top Journals